Device Trial Radar · NCT03748264
User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application
Last checked: Nov 19, 2026Latest source record: Mar 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
62
Actual
Start
Oct 21, 2013
Primary completion
May 27, 2014
Study completion May 27, 2014
Sponsor
- Lead sponsor
- Philips RespironicsPublic (PHG)
- Sponsor type
- Industry
- First posted
- Nov 20, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants will be recruited.
Conditions
- Sleep Disordered Breathing
Interventions
Standard of CareOther
In the standard of care or the control condition, participants will receive the sites therapy initiation standard of care for setting up and educating the participants on their Obstructive Sleep Apnea, mask, and device information. This group will use a wireless modem that is attached to the PAP device and uploads adherence and other therapy information daily to a secured database (Encore Anywhere). With this method, therapy information is not directly available to the participant but will continuously be available to site staff personnel.
DreamMapper ApplicationDevice
The DreamMapper application condition will receive the site's therapy initiation standard of care and will also download the DreamMapper application on their iPhone or Android smart phone. Therapy information and educational material will be available continuously to the participant with DreamMapper through the application. Study personnel will have access to adherence and therapy information continuously.
DreamMapper Application with Therapist AssistDevice
The DreamMapper with Therapist Assist will review the Therapist Assist automated educational material on Obstructive Sleep Apnea, their Philips Respironics mask and DreamMapper. These participants will download the DreamMapper application onto their iPhone or Android smart phone. Therapy information and educational material will be available continuously to the participant with DreamMapper. Study personnel will have access to adherence and therapy information continuously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- User Preference of the New Philips Respironics Positive Airway Pressure Application as Measured by the Attitudes Toward Use QuestionnaireTime frame: 90 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Paul Wylie, MD
Little Rock, Arkansas
Sleep Disorders Center of Georgia, Inc.
Atlanta, Georgia
Shalini Manchanda, MD
Indianapolis, Indiana
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.